These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 23424002)

  • 1. Reduced microglial CX3CR1 expression delays neurofibromatosis-1 glioma formation.
    Pong WW; Higer SB; Gianino SM; Emnett RJ; Gutmann DH
    Ann Neurol; 2013 Feb; 73(2):303-8. PubMed ID: 23424002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurofibromatosis-1 heterozygosity increases microglia in a spatially and temporally restricted pattern relevant to mouse optic glioma formation and growth.
    Simmons GW; Pong WW; Emnett RJ; White CR; Gianino SM; Rodriguez FJ; Gutmann DH
    J Neuropathol Exp Neurol; 2011 Jan; 70(1):51-62. PubMed ID: 21157378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA Sequencing of Tumor-Associated Microglia Reveals Ccl5 as a Stromal Chemokine Critical for Neurofibromatosis-1 Glioma Growth.
    Solga AC; Pong WW; Kim KY; Cimino PJ; Toonen JA; Walker J; Wylie T; Magrini V; Griffith M; Griffith OL; Ly A; Ellisman MH; Mardis ER; Gutmann DH
    Neoplasia; 2015 Oct; 17(10):776-88. PubMed ID: 26585233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NF1 germline mutation differentially dictates optic glioma formation and growth in neurofibromatosis-1.
    Toonen JA; Anastasaki C; Smithson LJ; Gianino SM; Li K; Kesterson RA; Gutmann DH
    Hum Mol Genet; 2016 May; 25(9):1703-13. PubMed ID: 26908603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased c-Jun-NH2-kinase signaling in neurofibromatosis-1 heterozygous microglia drives microglia activation and promotes optic glioma proliferation.
    Daginakatte GC; Gianino SM; Zhao NW; Parsadanian AS; Gutmann DH
    Cancer Res; 2008 Dec; 68(24):10358-66. PubMed ID: 19074905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spatiotemporal differences in CXCL12 expression and cyclic AMP underlie the unique pattern of optic glioma growth in neurofibromatosis type 1.
    Warrington NM; Woerner BM; Daginakatte GC; Dasgupta B; Perry A; Gutmann DH; Rubin JB
    Cancer Res; 2007 Sep; 67(18):8588-95. PubMed ID: 17875698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic and genomic alterations differentially dictate low-grade glioma growth through cancer stem cell-specific chemokine recruitment of T cells and microglia.
    Guo X; Pan Y; Gutmann DH
    Neuro Oncol; 2019 Oct; 21(10):1250-1262. PubMed ID: 31111915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrastructural characterization of the optic pathway in a mouse model of neurofibromatosis-1 optic glioma.
    Kim KY; Ju WK; Hegedus B; Gutmann DH; Ellisman MH
    Neuroscience; 2010 Sep; 170(1):178-88. PubMed ID: 20600672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optic nerve dysfunction in a mouse model of neurofibromatosis-1 optic glioma.
    Hegedus B; Hughes FW; Garbow JR; Gianino S; Banerjee D; Kim K; Ellisman MH; Brantley MA; Gutmann DH
    J Neuropathol Exp Neurol; 2009 May; 68(5):542-51. PubMed ID: 19525901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights into optic pathway glioma vision loss from mouse models of neurofibromatosis type 1.
    Freret ME; Gutmann DH
    J Neurosci Res; 2019 Jan; 97(1):45-56. PubMed ID: 29704429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asthma reduces glioma formation by T cell decorin-mediated inhibition of microglia.
    Chatterjee J; Sanapala S; Cobb O; Bewley A; Goldstein AK; Cordell E; Ge X; Garbow JR; Holtzman MJ; Gutmann DH
    Nat Commun; 2021 Dec; 12(1):7122. PubMed ID: 34880260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of coexisting genetic mutations on murine optic glioma biology.
    Kaul A; Toonen JA; Gianino SM; Gutmann DH
    Neuro Oncol; 2015 May; 17(5):670-7. PubMed ID: 25246427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NG2-cells are not the cell of origin for murine neurofibromatosis-1 (Nf1) optic glioma.
    Solga AC; Gianino SM; Gutmann DH
    Oncogene; 2014 Jan; 33(3):289-99. PubMed ID: 23318450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optic nerve glioma in mice requires astrocyte Nf1 gene inactivation and Nf1 brain heterozygosity.
    Bajenaru ML; Hernandez MR; Perry A; Zhu Y; Parada LF; Garbow JR; Gutmann DH
    Cancer Res; 2003 Dec; 63(24):8573-7. PubMed ID: 14695164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NF1 mutation-driven neuronal hyperexcitability sets a threshold for tumorigenesis and therapeutic targeting of murine optic glioma.
    Anastasaki C; Chatterjee J; Koleske JP; Gao Y; Bozeman SL; Kernan CM; Marco Y Marquez LI; Chen JK; Kelly CE; Blair CJ; Dietzen DJ; Kesterson RA; Gutmann DH
    Neuro Oncol; 2024 Aug; 26(8):1496-1508. PubMed ID: 38607967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNA sequence analysis reveals ITGAL/CD11A as a stromal regulator of murine low-grade glioma growth.
    De Andrade Costa A; Chatterjee J; Cobb O; Sanapala S; Scheaffer S; Guo X; Dahiya S; Gutmann DH
    Neuro Oncol; 2022 Jan; 24(1):14-26. PubMed ID: 34043012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen activation of microglia underlies the sexually dimorphic differences in Nf1 optic glioma-induced retinal pathology.
    Toonen JA; Solga AC; Ma Y; Gutmann DH
    J Exp Med; 2017 Jan; 214(1):17-25. PubMed ID: 27923908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defining the temporal course of murine neurofibromatosis-1 optic gliomagenesis reveals a therapeutic window to attenuate retinal dysfunction.
    Toonen JA; Ma Y; Gutmann DH
    Neuro Oncol; 2017 Jun; 19(6):808-819. PubMed ID: 28039362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optic glioma and precocious puberty in a girl with neurofibromatosis type 1 carrying an R681X mutation of NF1: case report and review of the literature.
    Kocova M; Kochova E; Sukarova-Angelovska E
    BMC Endocr Disord; 2015 Dec; 15():82. PubMed ID: 26666878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical cancer therapy in a mouse model of neurofibromatosis-1 optic glioma.
    Hegedus B; Banerjee D; Yeh TH; Rothermich S; Perry A; Rubin JB; Garbow JR; Gutmann DH
    Cancer Res; 2008 Mar; 68(5):1520-8. PubMed ID: 18316617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.